{"id":"https://openalex.org/W1987446423","doi":"https://doi.org/10.1097/00004714-199904000-00014","title":"Pindolol and Mianserin Augment the Antidepressant Activity of Fluoxetine in Hospitalized Major Depressed Patients, Including Those With Treatment Resistance","display_name":"Pindolol and Mianserin Augment the Antidepressant Activity of Fluoxetine in Hospitalized Major Depressed Patients, Including Those With Treatment Resistance","alternate_titles":[],"publication_year":1999,"publication_date":"1999-04-01","ids":{"openalex":"https://openalex.org/W1987446423","doi":"https://doi.org/10.1097/00004714-199904000-00014","mag":"1987446423","pmid":"https://pubmed.ncbi.nlm.nih.gov/10211920"},"language":"en","primary_location":{"id":"doi:10.1097/00004714-199904000-00014","doi":"https://doi.org/10.1097/00004714-199904000-00014","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-199904000-00014","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1987446423"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032880777","display_name":"Michael H. J. Maes","orcid":"https://orcid.org/0000-0002-2012-871X","observed_orcids":["https://orcid.org/0000-0002-2012-871X"]},"institutions":[{"id":"https://openalex.org/I149213910","display_name":"University of Antwerp","ror":"https://ror.org/008x57b05","country_code":"BE","type":"education","lineage":["https://openalex.org/I149213910"]},{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["BE","US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Michael Maes","raw_affiliation_strings":["Clinical Research Center for Mental Health, Antwerp, Belgium. m.maes@unicall.be","University of Antwerp","Vanderbilt University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Center for Mental Health, Antwerp, Belgium. m.maes@unicall.be","institution_ids":["https://openalex.org/I149213910"]},{"raw_affiliation_string":"University of Antwerp","institution_ids":["https://openalex.org/I149213910"]},{"raw_affiliation_string":"Vanderbilt University","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059507153","display_name":"Isabelle Libbrecht","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150429","display_name":"Ziekenhuisnetwerk Antwerpen Stuivenberg","ror":"https://ror.org/05dpzfc16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210150429","https://openalex.org/I4405261247"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Isabelle Libbrecht","raw_affiliation_strings":["AZ Stuivenberg"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AZ Stuivenberg","institution_ids":["https://openalex.org/I4210150429"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077377497","display_name":"Fran Van Hunsel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150429","display_name":"Ziekenhuisnetwerk Antwerpen Stuivenberg","ror":"https://ror.org/05dpzfc16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210150429","https://openalex.org/I4405261247"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fran van Hunsel","raw_affiliation_strings":["AZ Stuivenberg"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AZ Stuivenberg","institution_ids":["https://openalex.org/I4210150429"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083895684","display_name":"Dirk Campens","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dirk Campens","raw_affiliation_strings":["Akzo-Nobel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Akzo-Nobel","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108104383","display_name":"Herbert Y. Meltzer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Herbert Y. Meltzer","raw_affiliation_strings":["Vanderbilt University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University","institution_ids":["https://openalex.org/I200719446"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5032880777"],"corresponding_institution_ids":["https://openalex.org/I149213910","https://openalex.org/I200719446"],"apc_list":null,"apc_paid":null,"fwci":6.1985,"has_fulltext":false,"cited_by_count":146,"citation_normalized_percentile":{"value":0.96927651,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"19","issue":"2","first_page":"177","last_page":"182"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pindolol","display_name":"pindolol","score":0.9779999852180481},{"id":"https://openalex.org/keywords/mianserin","display_name":"mianserin","score":1.0},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.9919999837875366},{"id":"https://openalex.org/keywords/antidepressant-augmentation","display_name":"antidepressant augmentation","score":0.699999988079071},{"id":"https://openalex.org/keywords/treatment-resistant-depression","display_name":"treatment-resistant depression","score":0.9509999752044678},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.925000011920929},{"id":"https://openalex.org/keywords/5-ht1a-receptor-antagonist","display_name":"5-HT1A receptor antagonist","score":0.8790000081062317},{"id":"https://openalex.org/keywords/alpha2-adrenoceptor-antagonists","display_name":"alpha2-adrenoceptor antagonists","score":0.972000002861023},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9129999876022339}],"concepts":[{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.924433708190918},{"id":"https://openalex.org/C2778499207","wikidata":"https://www.wikidata.org/wiki/Q418101","display_name":"Pindolol","level":3,"score":0.9207133054733276},{"id":"https://openalex.org/C2780831388","wikidata":"https://www.wikidata.org/wiki/Q416701","display_name":"Mianserin","level":4,"score":0.8591945171356201},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.5897212028503418},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5196924805641174},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.47866782546043396},{"id":"https://openalex.org/C2780092697","wikidata":"https://www.wikidata.org/wiki/Q7455053","display_name":"Serotonin reuptake inhibitor","level":4,"score":0.4286675453186035},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42269569635391235},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.417781263589859},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.41192567348480225},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3968826234340668},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3282923698425293},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.2759134769439697},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07297253608703613},{"id":"https://openalex.org/C2778151854","wikidata":"https://www.wikidata.org/wiki/Q423364","display_name":"Propranolol","level":2,"score":0.06408452987670898},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008803","descriptor_name":"Mianserin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010869","descriptor_name":"Pindolol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004714-199904000-00014","doi":"https://doi.org/10.1097/00004714-199904000-00014","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-199904000-00014","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:10211920","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10211920","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical psychopharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1892978510","https://openalex.org/W1961428417","https://openalex.org/W1968885857","https://openalex.org/W2006177117","https://openalex.org/W2007046516","https://openalex.org/W2012047793","https://openalex.org/W2019797325","https://openalex.org/W2024305996","https://openalex.org/W2027011765","https://openalex.org/W2030526518","https://openalex.org/W2031431326","https://openalex.org/W2056521830","https://openalex.org/W2056726838","https://openalex.org/W2068965083","https://openalex.org/W2079669517","https://openalex.org/W2087763431","https://openalex.org/W2092326568","https://openalex.org/W2106405415","https://openalex.org/W2114613490","https://openalex.org/W2150215731","https://openalex.org/W2227468449","https://openalex.org/W2287278106","https://openalex.org/W2315845803","https://openalex.org/W2402252666","https://openalex.org/W2409250043","https://openalex.org/W2419075835"],"related_works":["https://openalex.org/W2106405415","https://openalex.org/W1969153521","https://openalex.org/W2150910901","https://openalex.org/W4252483862","https://openalex.org/W3027692322","https://openalex.org/W4256027943","https://openalex.org/W1976610164","https://openalex.org/W2031431326","https://openalex.org/W2733679677","https://openalex.org/W2012975250"],"abstract_inverted_index":{"The":[0,100,190,215],"aims":[1],"of":[2,29,40,42,48,115,154,225,230,243,245],"this":[3],"study":[4],"were":[5,65,143],"to":[6,58,73,120,130],"examine":[7],"whether":[8],"pindolol,":[9,237],"a":[10,18,31,69,160,180],"serotonin":[11,33],"(5-hydroxytryptamine":[12],"[5-HT])-1A":[13],"receptor":[14],"antagonist,":[15,23],"and":[16,20,36,50,139,205,220,232],"mianserin,":[17,234],"5-HT2A/C":[19],"alpha2-adrenoceptor":[21],"(alpha2-AR)":[22],"may":[24,238],"augment":[25,222],"the":[26,38,46,59,110,121,126,158,223,228,241],"clinical":[27],"efficacy":[28,116,224],"fluoxetine,":[30],"selective":[32],"reuptake":[34],"inhibitor,":[35],"shorten":[37,240],"latency":[39,242],"onset":[41,244],"antidepressive":[43,246],"activity":[44],"in":[45,157,166,184,227],"treatment":[47,229],"major":[49,62],"treatment-resistant":[51],"depression":[52],"(TRD).":[53],"Ten":[54],"days":[55],"after":[56,195],"admission":[57],"hospital,":[60],"31":[61],"depressed":[63],"patients":[64,167,185],"randomly":[66],"assigned":[67],"using":[68],"double-blind,":[70],"controlled":[71],"design":[72],"receive":[74],"fluoxetine":[75,79,89,136,140,148,171,175,188,197,213,226],"20":[76,80,90],"mg":[77,81,86,91,95],"daily,":[78,87],"daily":[82,96],"plus":[83,92,137,141,172,176,198],"pindolol":[84,138,173,219],"7.5":[85],"or":[88,174],"mianserin":[93,142,177,199,221],"30":[94],"for":[97,105],"5":[98],"weeks.":[99],"17-item":[101],"Hamilton":[102],"Rating":[103],"Scale":[104],"Depression":[106],"(HAM-D)":[107],"score":[108,192],"was":[109,117,133,164,206],"primary":[111],"outcome":[112,152],"measure.":[113],"Analysis":[114],"conducted":[118],"according":[119],"intent-to-treat":[122],"analysis":[123],"principle":[124],"considering":[125],"change":[127],"from":[128],"baseline":[129],"endpoint.":[131],"It":[132],"found":[134,165],"that":[135,210,218,233],"significantly":[144,207,239],"more":[145,201],"effective":[146],"than":[147,202,209],"alone.":[149,189,214],"Using":[150],"an":[151],"measure":[153],"50%":[155],"reduction":[156],"HAM-D,":[159],"60%":[161],"response":[162,182],"rate":[163,183],"treated":[168,186],"with":[169,179,187,250],"either":[170],"compared":[178],"9%":[181],"HAM-D":[191],"1":[193],"week":[194],"starting":[196],"decreased":[200],"4":[203],"points":[204],"greater":[208],"obtained":[211],"by":[212],"results":[216],"suggest":[217],"TRD":[231],"but":[235],"not":[236],"action":[247],"when":[248],"combined":[249],"fluoxetine.":[251]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1987446423","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
